CD80 and neoplasm: Christopher et al. prepared a tumor membrane vesicles (TMVs) vaccine, isolated TMVs from 4T1 tumor tissue, and modified immunostimulatory IL-12 and B7-1 (CD80) molecules on the surface of TMVs.